Paul Nyirjesy from Drexel University College of Medicine: Treating Chronic Vaginitis Improves with More in the Pipeline

Video

Chronic vaginitis is a fairly common condition but for the past decade few if any new treatments have been developed. While current treatments are effective there are new methods being developed for the future.

Chronic vaginitis is a fairly common condition but for the past decade few if any new treatments have been developed. While current treatments are effective there are new methods being developed for the future.

As the director of the Drexel Vaginitis Center Paul Nyirjesy, MD, said he has seen the field change dramatically in his time working in the field and is encouraged to see more work being done to help improve the quality of life of these patients.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
© 2024 MJH Life Sciences

All rights reserved.